Company: IXHL
Filing Date: 2025-07-24
Form Type: 8-K
Source: 0001213900-25-067374
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-07-24
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events

On July 24, 2025, Incannex
Healthcare Inc. (the “ Company”) filed a prospectus supplement to increase the capacity of its existing “at-the-market”
offering program (the “ ATM”) by up to an additional $100 million. While this filing increases the available capacity under
the ATM, the Company is under no obligation to issue any Shares pursuant to the program. The expanded facility
is intended to enhance the Company’s financial flexibility, providing an efficient mechanism to access capital if, and when, deemed
appropriate. Any utilisation of the ATM will be at the discretion of the Company, taking into account prevailing market conditions and
strategic priorities.

As previously disclosed,
the ATM is conducted pursuant to the Amended and Restated Sales Agreement, dated May 28, 2025 (the “ Amended and Restated Sales Agreement”)
by and among the Company, A. G. P./Alliance Global Partners (“ A. G. P.”) and Curvature Securities, LLC (“ Curvature,”
and together with A. G. P, the “ Sales Agents”). Accordingly, pursuant to the prospectus supplement, the amount of
shares of the Company’s common stock, par value $0.0001 per share (the “ Shares”), that the Company may issue under the
Amended and Restated Sales Agreement has been increased by up to an aggregate of $100 million of Shares. There can be no assurance that
the Sales Agents will be able to complete future placements pursuant to the Amended and Restated Sales Agreement, even if instructed to
do so. The number of Shares that the Company may ultimately sell under the Amended and Restated Sales Agreement, if it chooses to do so,
will fluctuate based on a number of factors, including the market price of its common stock during the sales period, the limits it may
set in any instruction to sell Shares, and the demand for its common stock during an applicable sales period.

Attached hereto as Exhibit
5.1 to this Current Report is the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C., relating to the legality of the issuance
and sale of the Shares.

Item 9.01 Financial Statements and Exhibits.